Waaree Energies has received order for supply of modules upto 180 Mwp from a renowned customer engaged in the business of owning, developing and operating renewable power projects in India. The supply of modules is scheduled to commence at the end of November 2024 and complete in Q4 of FY 2025.
Wipro has entered into strategic partnership with RELEX Solutions, a provider of unified supply chain and retail planning solutions. This partnership combines Wipro’s deep expertise in the retail and Consumer Packaged Goods (CPG) sectors with RELEX Solutions’ AI-based supply chain and retail planning platform. The platform enables retailers, wholesalers, and consumer goods companies to maximize sales, minimize costs, and reduce waste by optimizing demand, merchandise, supply chain, and operations planning across their value chain.
Kalpataru Projects International has received approval for the issuance of Unsecured, Rated, Listed, Redeemable, Non-Convertible Debentures (NCDs) of Rs 200 crore on private placement basis. The Executive Committee of the Board of Directors of the Company at its meeting held on November 6, 2024 has approved the same.
JTL Industries has pioneered as the L1 bidder for the Jal Jeevan Mission project, securing an order for the supply of ISI-certified Galvanized Mild Steel (GMS) tubes for 95% of the sizes, amounting to 35,473 MT of the total order. With an order value of Rs 265 crore, this win underscores JTL’s strong position in delivering high-quality, value-added products that meet critical government standards. This achievement highlights JTL's commitment to supporting vital infrastructure projects and contributing to the nation’s development.
Kwality Pharmaceuticals has successfully filed and got the approval for Leuprorelin Acetate 11.25 mg vial powder and solvent for injectable suspension as a site variation in Greece, marking its entry into the European Markets. Kwality Pharma will supply the first three validation batches in December and after complete Quality Control Analysis, will start regular supplies from January 2025 onwards.
Krishna Institute of Medical Sciences (KIMS) has planned to develop new medical facilities and acquire 3000 beds in Kerala over the next five years. KIMS Hospitals, currently has presence in the 5 states of Telangana, Andhra Pradesh, Maharashtra, Kerala and Karnataka with over 16 hospitals and 5000 plus beds. KIMS has already begun operations in Kerala by taking over Sreechand Hospital in Kannur and entering into an O&M contract with Westfort Hospital at Thrissur, where further development work is underway.
Apollo Hospitals Enterprise has reported results for second quarter ended September 30, 2024 (Q2FY25). The company has reported 25.37% rise in its net profit at Rs 369.60 crore for the quarter ended September 30, 2024 as compared to Rs 294.80 crore for the same quarter in the previous year. Total income of the company increased by 16.84% at Rs 2256.30 crore for Q2FY25 as compared to Rs 1931.10 crore for the corresponding quarter previous year. On consolidated basis, the company has reported 59.04% rise in net profit at Rs 395.70 crore for Q2FY25 as compared to Rs 248.80 crore for the same quarter in the previous year. Total income of the company increased by 15.58% at Rs 5627.50 crore for Q2FY25 as compared to Rs 4869.10 crore for the corresponding quarter previous year.
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through:
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
|
Name of the IA registered
with SEBI: |
The Alchemists Ark Pvt. Ltd. |
|
Logo:
|
|
|
Trade/Brand
Name of IA: |
MoneyWorks4Me Investment Advisers |
|
Brand Logo:
|
 |
|
SEBI Registration Number:
|
INA000013323 Validity – May 16, 2019 – Perpetual |
|
Registration:
|
Non-Individual |
|
BSE Enlistment No:
|
1187 |
|
Address:
|
B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045 |
|
Compliance Officer
Details: |
Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com |
Telephone: +919860359463 Address: Same as IA |
|
Grievance Officer
Details: |
Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com |
Telephone: +919860919463 Address: Same as IA |
|
Principal Officer
Details: |
Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com |
Telephone: +919175899463 Address: Same as IA |
|
Standard Warning:
|
Investment in securities market are subject to market risks. Read all the related documents carefully before investing. |
|
|
Disclaimer:
|
Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. |
|
